Skip to content
10-Q/A

Quarterly Report

Oncologix Tech Inc.

0001471242-15-000013

← back to feed
Filed
Jan 16, 2015 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · Jan 2, 2015 169.78M sh
Capex Q1 2015 · Nov 30, 2014 −$858
Operating Cash Flow Q1 2015 · Nov 30, 2014 −$195.9K
Short Term Debt Q1 2015 · Nov 30, 2014 $84.2K
Short Term Debt Q1 2015 · Aug 31, 2014 $82.53K
Cash And Equivalents Q1 2015 · Nov 30, 2014 $77.36K
Cash And Equivalents Q1 2015 · Aug 31, 2014 $17.5K
Stockholders Equity Q1 2015 · Nov 30, 2014 −$1.03M
Stockholders Equity Q1 2015 · Aug 31, 2014 −$664.72K
Current Liabilities Q1 2015 · Nov 30, 2014 $4.24M
Current Liabilities Q1 2015 · Aug 31, 2014 $2.4M
Total Liabilities Q1 2015 · Nov 30, 2014 $4.62M
Total Liabilities Q1 2015 · Aug 31, 2014 $2.8M
Current Assets Q1 2015 · Nov 30, 2014 $1.09M
Current Assets Q1 2015 · Aug 31, 2014 $274.63K
Total Assets Q1 2015 · Nov 30, 2014 $3.59M
Total Assets Q1 2015 · Aug 31, 2014 $2.14M
Sga Expense Q1 2015 · Nov 30, 2014 $454.32K
Rd Expense Q1 2015 · Nov 30, 2014 $10K
Net Income Q1 2015 · Nov 30, 2014 −$443.29K
Operating Income Q1 2015 · Nov 30, 2014 −$168.13K
Gross Profit Q1 2015 · Nov 30, 2014 $300.84K
Cost Of Revenue Q1 2015 · Nov 30, 2014 $861.03K
Revenue Q1 2015 · Nov 30, 2014 $1.16M